CID 132024

Cytoblastin

Structural Information

Molecular Formula
C28H34N4O4
SMILES
CC(C)C1C(=O)NC(CC2=CNC3=C(C=CC(=C23)N1C)C(C4=CNC5=CC=CC=C54)C(CO)O)CO
InChI
InChI=1S/C28H34N4O4/c1-15(2)27-28(36)31-17(13-33)10-16-11-30-26-19(8-9-22(24(16)26)32(27)3)25(23(35)14-34)20-12-29-21-7-5-4-6-18(20)21/h4-9,11-12,15,17,23,25,27,29-30,33-35H,10,13-14H2,1-3H3,(H,31,36)
InChIKey
NXVPLRFWXAISBZ-UHFFFAOYSA-N
Compound name
5-[2,3-dihydroxy-1-(1H-indol-3-yl)propyl]-13-(hydroxymethyl)-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4,6,8(15)-tetraen-11-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

3
References

46
Patents

490.258 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 491.26528 210.4
[M+Na]+ 513.24722 211.6
[M+NH4]+ 508.29182 210.6
[M+K]+ 529.22116 209.6
[M-H]- 489.25072 210.1
[M+Na-2H]- 511.23267 207.8
[M]+ 490.25745 210.5
[M]- 490.25855 210.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe